Proof and Evidence in Cases Involving Compensation for Damage Caused to Health or Life of a Citizen as a Result of the Use of Drugs for Medical Use

  • Yury A. SVIRIN Department of Civil Law and Process, Academy of Labor and Social Relations, Moscow, Russia
  • Alexandr A. MOKHOV Department of Business and Corporative Law, Moscow State Law University of Kutafin (MSAL), Moscow, Russia
  • Vladimir A. GUREEV Department of Civil Procedure, All-Russian State University of Justice, Law and Bailiff Organization, Moscow, Russia
  • Irina G. ANDROSOVA Department of Foreign Languages No.2, Plekhanov Russian University of Economics, Moscow, Russia
  • Sergey N. SHESTOV Department of Economics and Management, Institute of Economics and Law Academy of Labor and Social Relations, Sevastopol, Russia
  • Anna L. SHILOVSKAYA Russian State Social University (RSSU), Moscow, Russia

Abstract

The relevance of the investigated problem is caused by the ambiguous, contradictory jurisprudence in cases involving compensation for damage caused to health or life due to the use of drugs. In this connection, there arose a need of analysis of both the evidence examined by the court in resolving the above-mentioned categories of cases, and the proof process itself. This article aims to identify and disclose the general laws in proving the damage caused by drugs. This paper examines the evidence used in civil proceedings for compensation for damage caused by drugs; the necessity of securing of evidentiary presumption of guilt of a medical organization or manufacturer of medicines in the law; it also argues the duty of a medical institution or drug manufacturer to prove malice of the patient with caused bodily harm.

References

[1] Balibardina, N.G. 2006. The agreement to conduct clinical trials of medicinal products: the Dissertation of the candidate of legal sciences. Volgograd: VolSU. 189.
[2] Diveeva, N.I. 2015. Insurance as a means of social protection of participants in clinical trials of drugs for medical use. Medical Law, 2: 18-23.
[3] Kozminykh, E. 2001. Obligations owing to damage in the provision of medical services. Russian justice, 2:18-19.
[4] Kozminykh, E. 2002. Forensics for ‘doctor's case.’ Russian Justice, 3: 31-32.
[5] Maleina, M.N. 2014. Legal characteristics of health as an intangible benefit. Medical Law, 4: 12-16.
[6] Mokhov, A.A. 2004. Drugs as objects of civil rights. Lawyer, 12: 53-57.
[7] Vnukova, V.A. 2006. On the responsibility of the pharmaceutical companies for the sale of substandard drugs. Vestnik of Tambov University. Series: Humanities, 4: 65-67.

*** Approval of medicines storage rules. 2010. Order of the Ministry of Health and Social Development of the Russian Federation, dtd. August 23, 2010 No. 706n. RG. No. 231.
*** Approval of storage organization instructions for storage of different groups of medicines and medical products in the pharmaceutical institutions. 1996. Russian Ministry of Health Order, dtd. November 13, 1996, No. 377. RG. No. 238.
*** Approval of the procedure of appointment and prescription of drugs, as well as prescription forms for drugs, procedures for obtaining these forms, their recording and storage. 2013. Order of the Ministry of Health and Social Development of the Russian Federation, dtd. December 20, 2012 No. 1175n. RG. No. 142.
*** Approval of the Regulations on drugs for medical use production licensing. 2012. Russia Federation Government Resolution, dtd. July 6, 2012 No. 686. Legislation Bulletin of the Russian Federation, 29: 4116.
*** Approval of the requirements to the instructions for medical use of drugs. 2016. Russian Ministry of Health Order of September 21, 2016 No. 724n. RG. No. 233.
*** Bases of the healthcare of citizens in the Russian Federation. 2011. Federal Law, dtd. November 21, 2011 No. 323-FZ. Legislation Bulletin of the Russian Federation, 48: 6724.
*** Circulation of Medicines. 2010. Federal Law, dtd. April 12, 2010 No. 61-FZ. Legislation Bulletin of the Russian Federation, 16: 1815.
*** Consumer Rights Protection. 1992. Russian Federation Law, dtd. February 7, 1992 No. 2300-I. Gazette of the Congress of People's Deputies of the Russian Federation and the Supreme Soviet of the Russian Federation. No.15. Art. 766.
*** Licensing of certain types of activities. 2011. Federal Law, dtd. May 4, 2011 No. 99-FZ. Legislation Bulletin of the Russian Federation, 19: 2716.
*** Licensing of pharmaceutical activity. 2012. Russia Federation Government Resolution, dtd. December, 22 2011 No. 1081. Legislation Bulletin of the Russian Federation, 1: 126.
*** Resolution of the Plenum of the Supreme Court of the Russian Federation. 1994. Some issues of law application on compensation for moral damage. Bulletin of the European Court of Human Rights, 1: 25-28.
*** Resolution of the Plenum of the Supreme Court of the Russian Federation. 2010. Application by the courts of civil law regulating relations for the obligations due to damage to life or health of a citizen. Bulletin of the European Court of Human Rights, 3: 75-79.
*** The Civil Code of the Russian Federation. 2012. Federal Law No. 302-FZdtd. December 30. Available at: www.consultant.ru
*** The Civil Procedure Code of the Russian Federation. 2002. Federal Law of the Russian Federation No. 138-FZ of November 14. Available at: www.consultant.ru
*** The European Court of Human Rights judgment. 2009. Pitalev against the Russian Federation’ (ApplicationNo. 34393/03). Bulletin of the European Court of Human Rights.
*** The European Court of Human Rights judgment. 2013a. Case ‘Bortkevich against the Russian Federation’ (Application No. 27359/05). Bulletin of the European Court of Human Rights.
*** The European Court of Human Rights judgment. 2013b. E.A. against the Russian Federation (Application No. 44187/04). Bulletin of the European Court of Human Rights.
*** The procedure of appointment and prescription of drugs, medical devices and specialized clinical nutrition products. 2007. Order of the Ministry of Health and Social Development of the Russian Federation dtd. February 12, 2007 No. 110. RG. No. 100.
Published
2017-06-07
How to Cite
SVIRIN, Yury A. et al. Proof and Evidence in Cases Involving Compensation for Damage Caused to Health or Life of a Citizen as a Result of the Use of Drugs for Medical Use. Journal of Advanced Research in Law and Economics, [S.l.], v. 8, n. 1, p. 250-260, june 2017. ISSN 2068-696X. Available at: <https://journals.aserspublishing.eu/jarle/article/view/1151>. Date accessed: 15 nov. 2024.
Citation Formats
Issue
Vol 8 No 1 (2017): JARLE Volume VIII Issue 1 (23) Spring 2017
Section
Articles

The Copyright Transfer Form to ASERS Publishing (The Publisher)
This form refers to the manuscript, which an author(s) was accepted for publication and was signed by all the authors.
The undersigned Author(s) of the above-mentioned Paper here transfer any and all copyright-rights in and to The Paper to The Publisher. The Author(s) warrants that The Paper is based on their original work and that the undersigned has the power and authority to make and execute this assignment. It is the author's responsibility to obtain written permission to quote material that has been previously published in any form. The Publisher recognizes the retained rights noted below and grants to the above authors and employers for whom the work performed royalty-free permission to reuse their materials below. Authors may reuse all or portions of the above Paper in other works, excepting the publication of the paper in the same form. Authors may reproduce or authorize others to reproduce the above Paper for the Author's personal use or for internal company use, provided that the source and The Publisher copyright notice are mentioned, that the copies are not used in any way that implies The Publisher endorsement of a product or service of an employer, and that the copies are not offered for sale as such. Authors are permitted to grant third party requests for reprinting, republishing or other types of reuse. The Authors may make limited distribution of all or portions of the above Paper prior to publication if they inform The Publisher of the nature and extent of such limited distribution prior there to. Authors retain all proprietary rights in any process, procedure, or article of manufacture described in The Paper. This agreement becomes null and void if and only if the above paper is not accepted and published by The Publisher, or is with drawn by the author(s) before acceptance by the Publisher.